
Jefferies Sticks to Their Buy Rating for Lantheus (LNTH)

I'm PortAI, I can summarize articles.
Jefferies analyst Matthew Taylor maintains a Buy rating for Lantheus (LNTH) with a price target of $105.00. Taylor, who covers the Healthcare sector, has an average return of 7.7% and a 55.71% success rate. The analyst consensus on Lantheus is a Moderate Buy with an average price target of $77.83.
In a report released today, Matthew Taylor from Jefferies maintained a Buy rating on Lantheus, with a price target of $105.00.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Taylor covers the Healthcare sector, focusing on stocks such as Boston Scientific, Insulet, and Globus Medical. According to TipRanks, Taylor has an average return of 7.7% and a 55.71% success rate on recommended stocks.
Currently, the analyst consensus on Lantheus is a Moderate Buy with an average price target of $77.83.

